Daxor Corporation (DXR) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Daxor Corporation (DXR) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $51.2M, listed on NASDAQ, employing roughly 37 people, carrying a beta of 0.29 to the broader market. Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. Led by Michael Richard Feldschuh, public since 1983-07-25.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for DXR as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.